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Abstract: 
This article extends the order restricted inference approach for time-course or dose-response gene expression microarray 
data, introduced by Peddada and colleagues (2003) for the case when gene expression is heteroscedastic over time or dose.  
The new methodology uses an iterative algorithm to estimate mean expression at various times/doses when mean expression 
is subject to pre-defined patterns or profiles, known as order-restrictions.  Simulation studies reveal that the resulting 
bootstrap-based methodology for gene selection maintains the false positive rate at the nominal level while competing well 
with ORIOGEN in terms of power. The proposed methodology is illustrated using a breast cancer cell-line data analyzed by 
Peddada and colleagues (2003). 
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Background: 
Increasingly, researchers are interested in understanding 
changes in gene expression when an animal/tissue/cell line 
is exposed to a chemical/treatment over time and/or dose.  
For instance, researchers in the U.S. National Toxicology 
Program are conducting numerous gene expression studies 
to evaluate toxicity of a variety of chemicals on various 
tissues/organs in rodents using dose-response studies.   
There are a variety of reasons for conducting a dose-
response/time-course gene expression study. Sometimes a 
researcher may be interested in understanding the changes 
in gene expression at a specific time/dose relative to the 
control.  In other situations, a researcher may be interested 
in understanding the time-course pattern (or profile) of 
gene expression.  Accordingly, statistical methodology for 
the analysis of time-course/dose-response gene expression 
data has been an area of active research in recent years.  
Although the methodology described in this paper is 
equally applicable to both time- course and dose-response 
studies, for simplicity of exposition we shall only discuss 
time-course studies.  However, the same methodology may 
be applied to dose-response studies.  Further, this work is 
motivated by experiments where independent samples are 
obtained at different time points, unlike repeated measures 
or longitudinal studies.  
 
Depending upon the application, one may use a variety of 
available statistical methods for analysis.  For example, if 
the objective is to identify genes that have significantly 
different expression values between two specific doses or a 
dose and control, then one may use statistical procedures 
such as SAM (Statistical Analysis of Microarrays) [2, 19], 
BAMarray (Bayesian Analysis for Microarrays) [5, 6, 7], 
GA/KNN (Genetic Algorithm with K nearest neighbors) [8, 
9], etc.  However, if the objective is to select significant 
genes on the basis of their pattern/profile of expression 
over time, then one may use procedures such as 
Linear/Quadratic regression based method of Liu et al., 
[10], EDGE [18], ORIOGEN (Order Restricted Inference 
for Ordered Gene ExpressioN) [13, 14] etc. Each of these 
procedures identifies significant genes on the basis of their 
pattern of expression over time. The Linear/Quadratic 
regression based method of [10] is a very quick and simple 
methodology that fits standard linear and quadratic 
regression models for each gene over time. Based on the 
statistical significance of various regression coefficients, 
genes are clustered into groups.  The EDGE methodology 
of [18] may be viewed as a nonparametric version of. [10] 
EDGE exploits the smoothing spline models of [1] to fit 
gene expression over time. The machinery developed in [1] 
is specifically designed for repeated measurements on 
individuals.  Consequently, the EDGE methodology can be 
used for analyzing gene expression data under repeated 
measures setting as well.  Unlike regression procedures of 
[10] and EDGE, ORIOGEN is entirely nonparametric in 
the sense that no functional form and no distributional 
assumptions are made for gene expression over time 
(http://dir.niehs.nih.gov/dirbb/oriogen/index.cfm). Instead 
the procedure represents the mean expression over time by 
mathematical inequalities, known as order restrictions, and 
the P-values are determined by bootstrap methodology. 
Thus, the null hypothesis in ORIOGEN is that the mean 
gene expression is the same across all times and the 
alternative hypothesis is a union of all potential patterns 
declared of interest by the researcher. The software allows 
the researcher to provide a list of gene expression patterns 
of interest by clicking on radio buttons. The output not only 
selects statistically significant genes, but it also clusters 
genes with similar time-course profile. If a gene ontology 
database is available, then ORIOGEN can link the 
significant genes to the gene ontology database and provide 
further description on each selected gene. It has been 
demonstrated in [13] that ORIOGEN maintains the nominal Bioinformation by Biomedical Informatics Publishing Group                            open access 
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Type I error rates when the variances are homoscedastic. 
Throughout this paper the terms “Type I error” and 
“power” refer to the standard false positive and true 
positive rates for a given test.  They are not adjusted for 
multiple testing. Recently, several authors (c.f. [3, 15]) 
have discussed methods for analyzing gene expression data 
that control for false discovery rates. An important 
development in this field is the work of Datta and Datta. [3] 
They develop an empirical Bayes methodology for 
screening P-values so that the overall sensitivity of multiple 
testing is increased with a modest increase in false 
discovery rates.   
 
Most procedures described above, are based on the 
assumption that for each gene, the expression values are 
homoscedastic (i.e., have equal variance) across times. In 
practice this assumption may not be true.   
Heteroscedasticity (i.e., unequal variances over time) may 
arise for a number of reasons.  For instance, variability in 
gene expression could depend upon the mean expression 
value, or dose and/or duration of exposure. A potential 
consequence of heteroscedasticity is an increased false 
positive (and false discovery) rate and decreased power.   
Hence it is important to adjust for heteroscedasticity while 
analyzing gene expression data.  
 
In section 2 we provide a step by step description of the 
new methodology for selecting statistically significant 
genes and clustering genes with similar time-course 
profiles.  As in [12, 13, 14], all profiles are described by 
mathematical inequalities between the unknown 
parameters. We also compare the performance of the new 
procedure with ORIOGEN in terms of Type I error and 
power using a small simulation study. In section 3 we 
illustrate the proposed methodology using a data set 
described in Lobenhofer et al., [11] which was previously 
analyzed in. [13] Concluding remarks are provided in 
section 5 and in the Appendix we sketch the details of the 
proposed estimation and testing procedures.  
 
Throughout this paper we use the terms “profiles”, 
“patterns” and “order-restrictions” synonymously.   
Similarly, we use the terms “dose-response” and “time-
course” interchangeably. 
 
Methodology: 
For a given gene g,  g = 1, 2, …, G, let gij y denote its 
expression in the
th j sample,  ,   ,   ...   ,   2   , 1 gi n j = at the 
th i time period,  ,   ,   ...   ,   2   , 1 T i =  with 
2 () ,    () . gij gi gij gi Ey V a ry μ σ ==  In the following steps we 
describe the proposed methodology for evaluating the 
statistical significance of gene g and clustering genes with 
similar expression profiles over time. Throughout this 
paper  μdenotes the mean expression vector of suitable 
order. The order of μwould be clear from the context.  
Algorithm 1: 
Step 1 (Profiles specification)   
As in [13, 14], the researcher pre-selects all the time-course 
profiles of interest in the study in terms of k sets of 
inequalities between the mean expressions.  Thus, the 
desired parameter space of interest is 
T
k
p
p R ⊆ Θ = Θ
= U
1
where each subset  p Θ  represents a 
time course profile of interest.  
 
Two common profiles of interest are: (1) Increasing profile 
(simple order restriction), where 
}, .... | { 2 1 1 T
T R μ μ μ ≤ ≤ ≤ ∈ = Θ μ  with at 
least one strict inequality. (2) Up-down profile (umbrella 
order restriction), where 
}, ... .... | { 1 2 1 2 T s s
T R μ μ μ μ μ ≥ ≥ ≥ ≤ ≤ ≤ ∈ = Θ + μ
with at least one strict inequality.   
 
Similar to ORIOGEN, the proposed methodology tests the 
null hypothesis of no difference in mean expression over 
time, i.e gT g g H μ μ μ = = = .... : 2 1 0 , against the 
alternative that the mean expression has one of the forms 
described by  .
1
T
k
p
p R ⊆ Θ = Θ
= U  
 
Step 2 (Profile fitting)  
For each gene g we fit the observed expression values 
gij y against each profile  p Θ in the alternative hypothesis 
using the estimation procedure described in Appendix A1. 
For each fitted profile p Θ , we compute a goodness-of-fit 
statistic as described in Appendix A1 and select the profile 
with the largest goodness-of-fit statistic.  
 
Step 3 (Bootstrap significance)  
We evaluate the statistical significance of the largest 
goodness-of-fit statistic obtained in Step 2 using the 
bootstrap methodology. Since the data are heteroscedastic, 
the bootstrap methodology used in [13] is not appropriate; 
instead we use the bootstrap procedure described in 
Appendix A2. To keep the false positive and false 
discovery rates small, we advise the user to test the 
significance of each gene at a very small level of 
significance.   Further, since the level of significance is 
small, we run a large number of bootstraps.   
 
Genes with a P-value less than the pre-selected level of 
significance are selected as the significant genes. All 
significant genes with the same selected profile are 
clustered together.  
 
We compared the performance of the above methodology 
with ORIOGEN using a small simulation study.  The goal Bioinformation by Biomedical Informatics Publishing Group                            open access 
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is to compare the two procedures in terms of Type I error 
rate and the power.  In our simulation study we considered 
G = 1000 genes, T = 6 time points with 10 independent 
normally distributed random samples per time point.  For 
each gene g and time i the mean and variance patterns 
considered are as follows: A. Null hypothesis  ) 0 ( = gi μ  
with various patterns of variances:  
(1) Homoscedastic: , 16
2 = gi σ  
(2) Heteroscedastic: ,  
2 2 i gi = σ    (3) Strongly 
Heteroscedastic: .
3 2 i gi = σ B. Ordered alternative 
hypothesis with various patterns of variances:  
(4) Homoscedastic: , 16   ,
2 = = gi gi i σ μ   
(5) Heteroscedastic:  ,   ,
2 2 i i gi gi = = σ μ  (6) Strongly 
Heteroscedastic: 
23 , , gi gi ii μσ ==  (7) Umbrella 
profile: 
2 0, 16 gi gi μσ ==  for i = 1, 2, 4, 5, 6 and 
2
33 3, 9. gg μσ ==  
 
The funnel shaped heteroscedastic patterns considered 
above can be viewed as an “extreme” pattern in the sense 
that we expect this variance pattern to have greater impact 
on the false positive rate of test procedures based on 
homoscedastic variances than if the variance pattern has, 
for instance, an umbrella-shaped order restriction. We 
recognize that this is a small simulation study, but it 
conveys the drawbacks of procedures which do not account 
for heteroscedasticity and demonstrates that the 
modification proposed in this paper performs well.  It is 
also important to note that the amount of variation in the 
data considered in patterns (6) and (7) are very extreme 
compared to the differences among the means and hence in 
this case neither of the methods is expected to have good 
power.   
 
The results of our simulation study, based on 1000 
bootstrap samples at a level of significance of 0.05, are 
reported in Table 1. Patterns (1), (2) and (3) provide the 
Type I errors of the two procedures, whereas patterns (4), 
(5), (6) and (7) provide the power of the procedure.  As 
seen from Table 1, the new procedure (denoted as 
ORIOGEN-Hetero) never exceeds the nominal level of 
0.05, whereas ORIOGEN can be very liberal (larger Type I 
error than the nominal levels) as the amount of 
heteroscedasticity increases. For instance, in the case of 
patterns (2) and (3) the Type I error of ORIOGEN-Hetero 
is at most 0.03, whereas the ORIOGEN had a Type I error 
as high as 0.12. Not only does the new procedure have a 
Type I error rate within the nominal level of 0.05, it 
actually performs very well in terms of power when 
compared to ORIOGEN as seen in patterns (5), (6) and (7).  
Further, in the case of homoscedastic variances, pattern (4), 
the proposed procedure competes very well with 
ORIOGEN in terms of power.  
 
Method 
Pattern ) 6   ...,   , 2   , 1 ( = i   ORIOGEN ORIOGEN  -Hetero 
16    , 0    . 1
2 = = gi gi σ μ   0.04 0.04 
2 2    , 0    . 2 i gi gi = = σ μ   0.12 0.05 
3 2    , 0    . 3 i gi gi = = σ μ   0.11 0.03 
16    ,    . 4
2 = = gi gi i σ μ   0.66 0.64 
2 2    ,    . 5 i i gi gi = = σ μ   0.72 0.77 
3 2    ,    . 6 i i gi gi = = σ μ   0.24 0.25 
9    , 3
, 16    , 0    . 7
2
3 3
2
= =
= = =
g g
gi gi i
σ μ
σ μ
 
0.32 0.39 
Table 1:  Power and Type-I Error rate comparisons between ORIOGEN and ORIOGEN-Hetero 
 
Illustration: 
Lobenhofer et al., [11] conducted a microarray experiment 
to evaluate the effects of 17-β estrodial on the gene 
expression of MCF-7 breast cancer cells.  Microarrays were 
obtained after 1, 4, 12, 24, 36 and 48 hours of treatment.  
There were 8 cDNA chips per time point, and each chip 
had 1900 probes.  As done in [13], the gene expressions are 
log transformed. For each gene the null hypothesis was that 
the mean expression did not change over the 6 time points 
and the alternative was the union of 10 hypotheses as Bioinformation by Biomedical Informatics Publishing Group                            open access 
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follows: (1) mean expression is non-decreasing with time, 
(2) mean expression is non-increasing with time, (3,4,5,6) 
mean expression has an umbrella shape with peaks 4, 12, 
24, and 36 hours and (7,8,9,10) mean expression has an 
inverted umbrella with troughs at 4, 12, 24, and 36 hours.  
Before implementing the new procedure, we applied 
Hartley’s test for heteroscedasticity of variances.  The P-
values for the Hartley’s test statistic was computed by 
bootstrapping the residuals since the null distribution of the 
Hartley’s test is sensitive to normality assumption and gene 
expression data are not necessarily normally distributed. 
Using the usual level of significance of 0.05, we found that 
367 genes out of 1900 were heteroscedastic. At 0.10 level 
of significance, this number jumps up to 610 genes.  Thus 
there appears to be some amount of heteroscedasticity in 
the data which motivates us to apply the new methodology 
on this data. 
 
According to ORIOGEN, which assumes homoscedasticity 
of variances, 197 out of 1900 genes were statistically 
significant at a level of significance α= 0.005.  When we re-
analyzed the data using the new methodology ORIOGEN-
Hetero, we found 140 out of 1900 genes were significant at 
a level of significance α= 0.005. Of these 140, 115 were 
also selected by ORIOGEN.  These common genes are 
listed in the attached spreadsheet. Thus 82 genes were 
selected only by ORIOGEN while 35 were selected only by 
ORIOGEN-Hetero.  The discrepancy between these two 
procedures is possibly due to the amount of 
heteroscedasticity present in the data. 
 
Conclusions and Discussion: 
In this article we extended the order restricted inference 
procedure ORIOGEN of [13, 14] for the case when the 
gene expressions may be subject to unequal variance across 
time.  The new methodology, ORIOGEN-Hetero, uses an 
iterative algorithm to estimate the mean expression values 
subject to a given profile and statistical inferences are 
conducted by suitably bootstrapping the residuals. 
ORIOGEN and ORIOGEN-Hetero differ in both the 
method of estimation of parameters subject to order 
restrictions as well as the bootstrap methodology used in 
determining the P-values.  While ORIOGEN directly uses 
the point estimators developed in [4] under the assumption 
of equal variance across time for a given gene, ORIOGEN-
Hetero uses an iterated version of [4] where the unknown 
variances are estimated along with the means subject to 
order restrictions.  Further, by bootstrapping the residuals, 
ORIOGEN-Hetero allows heteroscedasticity, whereas in 
ORIOGEN resampling was performed by mixing samples 
from all time points for a given gene. 
 
A simulation study reported in this paper reveals that the 
new methodology performs well in controlling the Type I 
errors and hence is expected to perform well in controlling 
the overall false discovery rates when the gene expression 
data are subject to unequal variances across time.  Further, 
our modest simulation study suggests that the new method 
improves the power of the test as well when the variances 
are heteroscedastic.  However, as seen in our simulation 
study, when the variances are homoscedastic, the new 
method may lose power relative to ORIOGEN. One way to 
get around this problem is to perform a test procedure such 
as Hartley’s test for homoscedasticity of variances. Since 
Hartley’s test is not robust against non-normality and gene 
expression data are not necessarily normally distributed, P-
values for the Hartley’s test may be determined by 
bootstrapping appropriate residuals.  If the null hypothesis 
of homoscedasticity of variances is not rejected at some 
pre-specified level of significance of α, then one may 
implement ORIOGEN for such genes.  For genes where the 
null hypothesis of homoscedasticity of variances is rejected 
by Hartley’s test, then in such cases one may use the new 
method proposed in this paper.  Such a pre-testing strategy 
might increase the power while protecting the Type I error 
and false discovery rates. 
 
The resampling procedure used in ORIOGEN and 
ORIOGEN-Hetero does not allow for dependence in the 
samples across time as typically observed in a repeated 
measure study design. Estimation and testing for order 
restrictions under repeated measures design is a nontrivial 
generalization of the method described here.  In an ongoing 
project we are generalizing ORIOGEN to allow for 
repeated measures data.  
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Appendix: 
Throughout the Appendix we shall use the notations 
introduced in the main text. 
A1. Estimation of means subject to order restrictions 
under heteroscedasticity 
As in [12], we express each order restriction of interest on a 
parameter vector )' ,..., , ( 2 1 T μ μ μ μ = , by a graph 
where two components  i μ and  ,   , j i j ≠ μ are said to be 
linked if the inequality between the two is specified by the 
order restriction. For instance in the case of a simple order 
restriction all parameters are linked, whereas in the case of 
umbrella order 
} ... .... | { 1 2 1 2 T s s
T R μ μ μ μ μ ≥ ≥ ≥ ≤ ≤ ≤ ∈ = Θ + μ
, with at least one strict inequality, all parameters 
, 1     ,   , s j i j i ≤ < ≤ ∀ μ μ are linked and 
,     ,   , T j i s j i ≤ < ≤ ∀ μ μ are linked but 
T j s s i j i ≤ < < ≤ ∀   , 1     ,   , μ μ  are not linked.  A 
subgraph M formed by the subvector of μ is said to be a Bioinformation by Biomedical Informatics Publishing Group                            open access 
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linked subgraph if all parameters in the subvector are 
linked.  Thus in the case of simple order  1 Θ  every 
subvector of μ  is a linked subgraph whereas in the case of 
umbrella order  2 Θ , the subgraph formed by μ is not a 
linked subgraph since  T μ μ , 1 are not linked.  A linked 
subgraph M is said to be a maximally linked subgraph if for 
any linked subgraph N, if M ⊆  N then M = N.  The two 
extreme parameters of a maximally linked subgraph are 
said to be the farthest linked parameters of the maximally 
linked subgraph.  In the case of umbrella order 2 Θ , the 
two maximally linked subgraphs are: 
} .... | { 2 1 21 s
s R μ μ μ ≤ ≤ ≤ ∈ = Θ μ and
} .... | { 1
1
22 s T T
s T R μ μ μ ≤ ≤ ≤ ∈ = Θ −
+ − μ .  
In  21 Θ  the two farthest linked parameters are 
s μ μ   and   1 and in  22 Θ they are T s μ μ   and   . 
 
Hwang and Peddada [4] introduced a general methodology 
for estimating the mean vector  g μ  of gene g, for any 
arbitrary set of linear inequalities between the components 
of  g μ when the corresponding population variances 
, ,..., 2 , 1 ,
2 T i gi = σ are known.  Motivated by [17], for a 
given profile p Θ , in the following we propose a simple 
iterative scheme to estimate the mean vector p g Θ ∈ μ  
when the population variances  , ,..., 2 , 1 ,
2 T i gi = σ  are 
unknown. The basic idea is to invoke methodology in [4] at 
each iteration by using the estimates of the variances from 
the previous iteration as weights.    
 
Algorithm (Estimation of parameters for gene g under 
profile p Θ ) 
Step 1 (initial estimates):  Let 
gi
n
j
gij
gi gi n
y
y
gi
∑
= = =
1 ) 0 ( ˆ μ ,
1
) (
ˆ  
1
2
2 ) 0 ( 2
−
−
= =
∑
=
gi
n
j
gi gij
gi gi n
y y
s
gi
σ , ) 0 ( 2
) 0 (
ˆ
 
gi
gi
gi
n
w
σ
= . 
Step 2 (
th r  iterate,   ...   , 2   , 1 = r ): Apply the 
methodology in [4] on the 
estimates, )' ˆ ,..., ˆ , ˆ ( ˆ
) 1 ( ) 1 (
2
) 1 (
1
) 1 ( − − − − =
r
gT
r
g
r
g
r
g μ μ μ μ , with 
weights )' ,..., , (  
) 1 ( ) 1 (
2
) 1 (
1
) 1 ( − − − − =
r
gT
r
g
r
g
r
g w w w w , 
obtained in the (r-1)
th iterate. Denote the resulting estimates 
by  
  
  , )' ˆ ,..., ˆ , ˆ ( ˆ
) ( ) (
2
) (
1
) ( r
gT
r
g
r
g
r
g μ μ μ μ =
T i
n
y
gi
n
j
r
gi gij
r
gi
gi
  ,   ...   , 2   , 1    ,
1
) ˆ (
ˆ  
1
2 ) (
) ( 2 =
−
−
=
∑
=
μ
σ
  
and 
)'
ˆ
,...,
ˆ
,
ˆ
( )' ,..., , (   ) ( 2 ) ( 2
2
2
) ( 2
1
1 ) ( ) (
2
) (
1
) (
r
gT
gT
r
g
g
r
g
g r
gT
r
g
r
g
r
g
n n n
w w w w
σ σ σ
= = .  If 
any of the denominators is zero, as in [16] we replace it by 
an arbitrarily small positive real number. 
 
Step 3 (Convergence): Repeat Step 2 until 
,     || ˆ ˆ ||
2
2
) ( ) 1 ( δ μ μ < −
+ r
g
r
g  where   || . ||
2
2 is the square of 
the usual L2 norm and δ is some small positive constant. In 
the simulations contained herein,δ is chosen to be 0.0001.  
Upon convergence, the estimates are denoted by 
)' ˆ ,..., ˆ , ˆ ( ˆ 2 1 gT g g g μ μ μ = μ  
and
1
) ˆ (
ˆ  
1
2
2
−
−
=
∑
=
gi
n
j
gi gij
gi n
y
gi
μ
σ . 
 
For normally distributed data, with p Θ satisfying the 
simple order restriction, Shi and Jiang [17] discussed the 
convergence of the above algorithm.  Although in this 
paper we do not discuss the convergence of the above 
algorithm for the general linear inequality restrictions, 
extensive simulation studies, using an umbrella order 
restriction, suggest that the above algorithm converges 
rapidly. On average it took less than 10 iterations in the 
simulations we performed.   
 
Step 4 (Computation of goodness-of-fit statistic):  For 
profile p Θ , identify all maximally linked subgraphs.   
Within each maximally linked subgraph identify the 
farthest linked parameters.  Then the goodness-of-fit 
statistic for  p Θ  is defined as the maximum studentized 
difference between the estimates of two farthest linked 
parameters, where maximum is taken over all maximally 
linked subgraphs.  Denote the statistic by  . ) (
∞
g p l This can 
be viewed as the standard infinity norm of a vector. Bioinformation by Biomedical Informatics Publishing Group                            open access 
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Examples:  For simple order 
} .... | { 2 1 1 T
T R μ μ μ ≤ ≤ ≤ ∈ = Θ μ the only 
maximally linked subgraph is  1 Θ  itself and the two 
farthest linked parameters are  .   and   1 T μ μ  Thus here  
1
2
1
2
1
) ( 1
ˆ ˆ
ˆ ˆ
g
g
gT
gT
g gT
g
n n
l
σ σ
μ μ
+
−
=
∞ . 
However, for the umbrella order, 
} ... .... | { 1 2 1 2 T s s
T R μ μ μ μ μ ≥ ≥ ≥ ≤ ≤ ≤ ∈ = Θ + μ , 
the two maximally linked subgraphs are  21 Θ  and  22 Θ  
with farthest linked parameters  s μ μ    , 1 and  T s μ μ   , , 
respectively. Thus in this case 
.
ˆ ˆ
ˆ ˆ
    ,
ˆ ˆ
ˆ ˆ
max
2 2
1
2
1
2
1
) ( 2
⎟
⎟
⎟
⎟
⎟
⎟
⎠
⎞
⎜
⎜
⎜
⎜
⎜
⎜
⎝
⎛
+
−
+
−
=
∞
gT
gT
gs
gs
gT gs
g
g
gs
gs
g gs
g
n n n n
l
σ σ
μ μ
σ σ
μ μ
 
 
A2.  Bootstrap procedure for testing under 
heteroscedasticity 
  For each gene g and time point i obtain the residuals 
, ,   ...   , 2   , 1 , gi gi gij gij n j y y e = − =   . ,   ...   , 2   , 1 T i =  
Next within the i
th time point draw a simple random sample 
of size gi n  (with replacement) from 
}. ,...., , { 2 1 gi gin gi gi e e e  Denote the resampled residuals 
by  }. ,...., , {
* *
2
*
1 gi gin gi gi e e e  Then the bootstrap data 
*
gij y are obtained by ,  
* *
gij g gij e y y + =  where 
.  
1
1
∑
∑
=
= =
T
i
gi
T
i
gi gi
g
n
y n
y  Using this bootstrap data apply Step 
2 of Algorithm 1. This process is repeated a large number 
of times to derive the null distribution of the test statistic 
required for testing the significance of a gene g in Step 3 of 
Algorithm  
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